Recent Publications in Addiction Medicine

Recent publications

• Shame and stigma in association with the HCV cascade to cure among people who inject drugs. Batchelder AW, Heo M, Foley JD, Sullivan MC, Lum P, Pericot Valverde I, Taylor LE, Mehta SH, Kim AY, Norton B, Tsui JI, Feinberg J, Page K, Litwin AH; HERO Study Group. Drug Alcohol Depend. 2023 Oct 31;253:111013. doi: 10.1016/j.drugalcdep.2023.111013. Epub ahead of print. PMID: 37951006.

• Influence of patient trust in provider and health literacy on receipt of guideline-concordant chronic opioid therapy in HIV care settings. Williams EC, Frost MC, Lodi S, Forman LS, Lira MC, Tsui JI, Lunze K, Kim T, Liebschutz JM, Rio CD, Samet JH. J Opioid Manag. 2023 Sep-Oct;19(5):385-393. doi: 10.5055/jom.0812. PMID: 37968972.

• Presentation and Outcomes of Adults with Overdose-Related Out-of-Hospital Cardiac Arrest. Vidhushei Yogeswaran, Christopher Drucker, Kosuke Kume, Amy Poel, Nicole Yarid, Sarah Leyde, Thomas D. Rea, Neal A. Chatterjee. JAMA Netw Open. 2023;6(11):e2341921. doi:10.1001/jamanetworkopen.2023.41921

• Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial. Wartko PD, Bobb JF, Boudreau DM, … Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA; PROUD Trial Collaborators; Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP. JAMA Intern Med. 2023 Oct 30. doi: 10.1001/jamainternmed.2023.5701. Online ahead of print. PMID: 37902748.

• Adaptation of the collaborative care model to integrate behavioral health care into a low-barrier HIV clinic. Dombrowski JC, Halliday S, Tsui JI, Rao D, Sherr K, Ramchandani MS, Emerson R, Fleming M, Wood T, Chwastiak L. Implement Res Pract. 2023 Apr 17;4:26334895231167105. doi: 10.1177/26334895231167105. PMID: 37790178; PMCID: PMC10123894.

• Hepatitis C treatment in people living with HIV: Potential to eliminate disease and disparity. Falade-Nwulia O, Lesko CR, Fojo AT, Keruly JC, Moore RD, Sutcliffe CG, Mehta SH, Chander G, Thomas DL, Sulkowski M. J Infect Dis. 2023 Oct 5:jiad433. doi: 10.1093/infdis/jiad433. Online ahead of print. PMID: 37793170.

• Assessing the associations between known genetic variants and substance use in people with HIV in the United States. Haas CB, Jordahl KM, Nance RM, Whitney BM, Wang L, Delaney JAC, Ruderman S, Jia T, Mathews WC, Saag MS, Lee SA, Napravnik S, Jacobson JM, Chander G, McCall EM, Moore RD, Mayer KH, Mukherjee S, Lee WJ, Crane PK, Crane H, Peter I, Lindström S. PLoS One. 2023 Oct 5;18(10):e0292068. doi: 10.1371/journal.pone.0292068. eCollection 2023. PMID: 37796845.

• Racial disparities in use of syringe service programs in King County, WA: A comparison of two cross-sectional surveys. Katheryn Salow, Helen E. Jack, Joe Tinsley, Caleb J. Banta-Green, Susan Kingston, Matthew Iles-Shih, Judith I. Tsui & Sara Glick. Harm Reduct J 20, 133 (2023). https://doi.org/10.1186/s12954-023-00868-w.

• Weighing cessation: Rising adiposity of current smokers in NHANES. Ellison-Barnes A, Yeh HC, Pollack CE, Daumit GL, Chander G, Galiatsatos P, Gudzune KA. Prev Med. 2023 Sep 25:107713. doi: 10.1016/j.ypmed.2023.107713. Online ahead of print. PMID: 37758125.

• Critical care for patients with substance use disorders. Steel TL, Bhatraju EP, Hills-Dunlap K. Curr Opin Crit Care. 2023 Oct 1;29(5):484-492. doi: 10.1097/MCC.0000000000001080. Epub 2023 Jul 31. PMID: 37641506 Review.

• Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use. Pytell JD, Fojo AT, Keruly JC, Snow LN, Falade-Nwulia O, Moore RD, Chander G, Lesko CR. Addict Sci Clin Pract. 2023 Sep 2;18(1):51. doi: 10.1186/s13722-023-00408-8. PMID: 37660116.

• A Digital Counselor-Delivered Intervention for Substance Use Among People With HIV: Development and Usability Study. Hutton HE, Aggarwal S, Gillani A, Chander G. JMIR Form Res. 2023 Aug 28;7:e40260. doi: 10.2196/40260. PMID: 37639294.

• Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs. Tsui JI, Whitney BM, Korthuis PT, Chan B, Pho MT, Jenkins WD, Young AM, Cooper HLF, Friedmann PD, Stopka TJ, de Gijsel D, Miller WC, Go VF, Westergaard R, Brown R, Seal DW, Zule WA, Feinberg J, Smith GS, Mixson LS, Fredericksen R, Crane HM, Delaney JA; Rural Opioid Initiative Consortium. Drug Alcohol Depend. 2023 Aug 2;250:110911. doi: 10.1016/j.drugalcdep.2023.110911. Epub ahead of print. PMID: 37549545.

• Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. Lesko CR, Falade-Nwulia OO, Pytell JD, Hutton HE, Fojo AT, Keruly JC, Moore RD, Chander G. Addiction. 2023 Jul 25. doi: 10.1111/add.16301. Online ahead of print. PMID: 37491566.

• An Attendance-based Contingency Management Pilot Program for Veterans Experiencing Homelessness With Stimulant-associated Cardiomyopathy in Primary Care. Tuegel C, Farris SD, Kantner CW, Leyde S, DePhilippis D, Kennedy AJ. J Addict Med. 2023 Jun 1. doi: 10.1097/ADM.0000000000001186. Epub ahead of print. PMID: 37261905.

• Alcohol use and the longitudinal HIV care continuum for people with HIV who enrolled in care between 2011-2019. Lesko CR, Gnang JS, Fojo AT, Hutton HE, Mccaul ME, Delaney JA, Cachay ER, Mayer KH, Crane HM, Scott Batey D, Napravnik S, Christopoulos KA, Lau B, Chander G. Ann Epidemiol. 2023 Jul 11:S1047-2797(23)00139-4. doi: 10.1016/j.annepidem.2023.07.002. Online ahead of print. PMID: 37442307.

• Workload, Usability, and Engagement with a Mobile App Supporting Video Observation of Methadone Take-Home Dosing: Usability Study. Idrisov B, Hallgren KA, Michaels A, Soth S, Darnton J, Grekin P, Woolworth S, Saxon AJ, Tsui JI. JMIR Hum Factors. 2023 Jul 13;10:e42654. doi: 10.2196/42654. PMID: 37440298.

• Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder. Bhatraju EP, Radick AC, Leroux BG, Kim TW, Samet JH, Tsui JI. Am J Drug Alcohol Abuse. 2023 Jun 27:1-8. doi: 10.1080/00952990.2023.2220876. Online ahead of print. PMID: 37369019.

• Tobacco Smoking and Pack-years are Associated with Frailty Among People with HIV.  Ruderman SA, Odden MC, Webel AR, Fitzpatrick AL, Crane PK, Nance RM, … McCaul M, Chander G, Cachay E, Lober WB, Kritchevsky SB, Austad S, Landay A, Pandya C, Cartujano-Barrera F, Saag MS, Kamen C, Hahn AW, Kitahata MM, Delaney JA, Crane HM. J Acquir Immune Defic Syndr. 2023 Jun 26. doi: 10.1097/QAI.0000000000003242. Online ahead of print. PMID: 37368939.

• Substance Use and Mental Health Comorbidities and Receipt of Specialty Care Among Patients Enrolled in a Low-Barrier HIV Clinic. Altwies EE, Zinsli KA, Chwastiak L, Tsui JI, Bhatraju EP, Ramchandani MS, Golden MR, Dombrowski JC. AIDS Behav. 2023 Jun 23. doi: 10.1007/s10461-023-04110-3. Online ahead of print. PMID: 37351687.

• Changes in alcohol consumption reported on routine healthcare screenings are associated with changes in depression symptoms. Hallgren KA, Jack HE, Oliver M, Berger D, Bobb JF, Kivlahan DR, Bradley KA. Alcohol (Hanover). 2023 Jun 16. doi: 10.1111/acer.15075. Online ahead of print. PMID: 37326806.

• HIV stigma and disclosure of alcohol use to physicians: examining the mediating role of depression among persons living with HIV. Kane JC, Mauro PM, Hahn JA, Chander G, Tobin KE, Martins SS, Paniagua-Avila A, Latkin CA. AIDS Care. 2023 Jun 14:1-6. doi: 10.1080/09540121.2023.2214864. Online ahead of print. PMID: 37314960.

• Use of Video Directly Observed Therapy and Characteristics Associated With Use Among Patients Treated With Buprenorphine in an Office-based Setting. Radick AC, James J, Leroux BG, Kim TW, Saxon AJ, Samet JH, Tsui JI. J Addict Med. 2023 May-Jun 01;17(3):300-304. doi: 10.1097/ADM.0000000000001103. Epub 2022 Oct 25. PMID: 37267172 Clinical Trial.

• A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences. Karasz A, Merchant K, Arnsten J, Feinberg J, Kim AY, Lum PJ, McKee MD, Mehta SH, Meissner P, Norton BL, Page K, Pericot-Valverde I, Singh R, Stein E, Taylor LE, Tsui JI, Wagner K, Litwin A. J Med Internet Res. 2023 Jun 2;25:e38176. doi: 10.2196/38176. PMID: 37266986.

• Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study. Geist ML, Radick AC, Tsui JI, Blalock KL, Adwell A, Tamru E, Connolly NC, James JR. Addict Sci Clin Pract. 2023 May 25;18(1):33. doi: 10.1186/s13722-023-00389-8. PMID: 37231486.

• Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. Kimberly L. Sue, Marek Chawarski, Leslie Curry, Ryan McNeil, Edouard Coupet Jr, Robert P. Schwartz, Christine Wilder, Judith I. Tsui, Kathryn F. Hawk, Gail D’Onofrio, Patrick G. O’Connor, David A. Fiellin, E. Jennifer Edelman. JAMA Netw Open. 2023;6(5):e2312718. doi:10.1001/jamanetworkopen.2023.12718.

• Training Providers of People Who Use Drugs to Offer Hepatitis C Treatment: A Washington State Initiative. James JR, Tsui JI. Substance Abuse. 2023;0(0). doi:10.1177/08897077231167047.

• Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs. Sue KL, Chawarski M, Curry L, McNeil R, Coupet E Jr, Schwartz RP, Wilder C, Tsui JI, Hawk KF, D'Onofrio G, O'Connor PG, Fiellin DA, Edelman EJ. JAMA Netw Open. 2023 May 1;6(5):e2312718. doi: 10.1001/jamanetworkopen.2023.12718. PMID: 37163263.

• Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs. Tsui JI, Lum PJ, Taylor LE, Mehta SH, Feinberg J, Kim AY, Norton BL, Niu J, Heo M, Arnsten J, Pericot-Valverde I, Thomas A, Blalock KL, Radick A, Murray-Krezan C, Page K, Litwin AH; HERO Study Group. Drug Alcohol Depend. 2023 Apr 17;247:109878. doi: 10.1016/j.drugalcdep.2023.109878. Epub ahead of print. PMID: 37150144.

• "Another tool in the toolkit"-Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site. Perlmutter D, Wettemann C, Fockele CE, Frohe T, Williams W, Holland N, Oliphant-Wells T, Meischke H, van Draanen J. Int J Drug Policy. 2023 May;115:104005. doi: 10.1016/j.drugpo.2023.104005. Epub 2023 Mar 25. PMID: 36972652.

• A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies. Morse SC, Fockele C, Huynh LN, Zatzick A, Whiteside LK. Int J Emerg Med. 2023 Apr 28;16(1):30. doi: 10.1186/s12245-023-00505-0. PMID: 37106338.

• Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. J Subst Use Addict Treat. 2023 Apr 21:209055. doi: 10.1016/j.josat.2023.209055. Online ahead of print. PMID: 37088398.

• Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. D'Onofrio G, Edelman EJ, Hawk KF, Chawarski MC, Pantalon MV, Owens PH, Martel SH, Rothman R, Saheed M, Schwartz RP, Cowan E, Richardson L, Salsitz E, Lyons MS, Freiermuth C, Wilder C, Whiteside L, Tsui JI, Klein JW, Coupet E, O'Connor PG, Matthews AG, Murphy SM, Huntley K, Fiellin DA. JAMA Netw Open. 2023 Apr 3;6(4):e235439. doi: 10.1001/jamanetworkopen.2023.5439. PMID: 37017967.

• "Sign Me Up": A qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic. Darnton JB, Bhatraju EP, Beima-Sofie K, Michaels A, Hallgren KA, Soth S, Grekin P, Woolworth S, Tsui JI. Addict Sci Clin Pract. 2023 Mar 29;18(1):21. doi: 10.1186/s13722-023-00372-3. PMID: 36991506; PMCID: PMC10052285.

• Patient and stakeholder perspectives on impacts of the COVID-19 pandemic on HIV and mental health care delivery in South Africa. Alexandra L Rose, Yvonne A Ochieng, Helen E Jack, Anu Sangraula, Nonceba Ciya, Yuche Jacobs, Sibabalwe Ndamase, Kristen S Regenauer, Imani Brown, Abigail C Hines, Kim Johnson, Ingrid V Bassett, John A Joska, Jessica F Magidson, and Bronwyn Myers. International Journal of STD & AIDS. 2023;0(0). doi:10.1177/09564624231160581.

• Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations. Cook RR, Foot C, Arah OA, Humphreys K, Rudolph KE, Luo SX, Tsui JI, Levander XA, Korthuis PT. Addict Sci Clin Pract. 2023 Feb 14;18(1):11. doi: 10.1186/s13722-023-00364-3. PMID: 36788634; PMCID: PMC9930351.

  The experience of re-infection among people who inject drugs successfully treated for hepatitis C. Karasz A, Merchant K, Singh R, Thomas A, Borsuk C, McKee D, Duryea P, Kim AY, Mehta S, Norton BL, Page K, Pericot-Valverde I, Sedillo S, Stein ES, Taylor LE, Tsui J, Litwin A. J Subst Use Addict Treat. 2023 Mar;146:208937. doi: 10.1016/j.josat.2022.208937. Epub 2023 Jan 6. PMID: 36880897.

• Association between clinical measures of unhealthy alcohol use and subsequent year hospital admissions in a primary care population. Helen E. Jack, Malia M. Oliver, Douglas B. Berger, Jennifer F. Bobb, Katharine A. Bradley, Kevin A. Hallgren. Drug and Alcohol Dependence. Volume 245, 1 April 2023, 109821.

• Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine. Tsui JI, Stephens D, Collins B, Denisiuk E, Hallgren KA, Blalock KL, Klein JW, Jack HE, Merrill JO. J Addict Med. 2023 Jan 17. doi: 10.1097/ADM.0000000000001129. Epub ahead of print. PMID: 36728182.

• Ending Medical Complicity With Skilled-Nursing Facility Discrimination Against People With Opioid Use Disorder. Cohen SM, Joab R, Bolles KM, Friedman S, Kimmel SD. Ann Intern Med. 2023 Feb 7. doi: 10.7326/M22-3049. Online ahead of print. PMID: 36745883.

• Lessons from the implementation of a trauma center-based program to support primary care providers in managing opioids and pain after trauma hospitalization. Baldwin LM, Katers LA, Sullivan MD, Gordon DB, James A, Tauben DJ, Arbabi S. Trauma Surg Acute Care Open. 2023 Feb 20;8(1):e001038. doi: 10.1136/tsaco-2022-001038. eCollection 2023. PMID: 36844370.

• Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trial. Hahn JA, Fatch R, Emenyonu NI, Sanyu N, Katusiime A, Levine B, John Boscardin W, Chander G, Hutton H, Camlin CS, Woolf-King SE, Muyindike WR. Drug Alcohol Depend. 2023 Jan 21;244:109783. doi: 10.1016/j.drugalcdep.2023.109783. Online ahead of print. PMID: 36706675.

• A Mixed-methods Evaluation of an Addiction/Cardiology Pilot Clinic With Contingency Management for Patients With Stimulant-associated Cardiomyopathy. Leyde, Sarah; Abbs, Elizabeth; Suen, Leslie W.; Martin, Marlene; Mitchell, Andreas; Davis, Jonathan; Azari, Soraya. Journal of Addiction Medicine ():10.1097/ADM.0000000000001110, December 16, 2022. | DOI: 10.1097/ADM.0000000000001110.

• Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs. Austin EJ, Gojic AJ, Bhatraju EP, Pierce KA, Pickering EI, Tung EL, Scott JD, Hansen RN, Glick SN, Stekler JD, Connolly NC, Villafuerte S, McPadden M, Deutsch S, Ninburg M, Kubiniec R, Williams EC, Tsui JI. Int J Drug Policy. 2022 Dec 13;111:103924. doi: 10.1016/j.drugpo.2022.103924. Online ahead of print. PMID: 36521197.

• Clinician Perceptions of Receiving Different Forms of Feedback on their Opioid Prescribing. Klaiman T, Nelson MN, Yan XS, Navathe AS, Patel MS, Refai F, Delgado MK, Pagnotti DR Jr, Liao JM. Am J Med Qual. 2023 Jan-Feb 01;38(1):1-8. doi: 10.1097/JMQ.0000000000000092. Epub 2022 Dec 29. PMID: 36579960 Clinical Trial.

• Substance use disorder treatment and technology access among people who use drugs in rural areas of the United States: A cross-sectional survey. Button D, Levander XA, Cook RR, Miller WC, Salisbury-Afshar EM, Tsui JI, Ibragimov U, Jenkins WD, Westergaard RP, Korthuis PT. J Rural Health. 2022 Dec 27. doi: 10.1111/jrh.12737. Online ahead of print. PMID: 36575145.